Guojie Long
Guangdong Provincial Key Laboratory Of Colorectal And Pelvic Floor Disease
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Autophagy Orchestrates Anti-Tumor Immunity to Enhance Chemosensitivity via the FBXW2/C/EBPβ/TIMP-2 Axis in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 09, 2026
A serum metabolite-based machine learning model predicts response to neoadjuvant immunotherapy in mismatch repair-deficient colorectal cancer.
Journal: Frontiers in oncology
Published: October 22, 2025
Hepatocyte-derived LRG1 primes the liver for metastasis and impairs immunotherapy.
Journal: Cellular & molecular immunology
Published: September 02, 2025
Metabolic dysfunction-associated steatotic liver disease increases the incidence of metachronous liver metastases from TNM stage 0-II colorectal cancer.
Journal: Hepatology international
Published: January 21, 2025
Single-cell transcriptomic analysis reveals dynamic changes in the liver microenvironment during colorectal cancer metastatic progression.
Journal: Journal of translational medicine
Published: December 02, 2024
KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGF‑β mediated epithelial‑mesenchymal transition.
Journal: Molecular medicine reports
Published: August 09, 2024
Targeting PKC as a Therapeutic Strategy to Overcome Chemoresistance in TNBC by Restoring Aurora Kinase B Expression.
Journal: Journal of cellular and molecular medicine
Published: May 07, 2024
Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma.
Journal: Frontiers in oncology
Published: March 03, 2023
Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344.
Journal: Cancers
Published: December 07, 2022
Circ_0020256 induces fibroblast activation to drive cholangiocarcinoma development via recruitment of EIF4A3 protein to stabilize KLF4 mRNA.
Journal: Cell death discovery
Published: October 17, 2022
Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
Journal: Cancers
Published: September 29, 2022
SHH/GLI2-TGF-β1 feedback loop between cancer cells and tumor-associated macrophages maintains epithelial-mesenchymal transition and endoplasmic reticulum homeostasis in cholangiocarcinoma.
Journal: Pharmacological research
Published: August 16, 2022
Last Updated: 09/26/2026